New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
February 4, 2022 - Merck announced the permanent discontinuation of Intron A (interfereon alfa-2b).
Download PDF
Return to publications
